Responsive Advertisement

Friday, December 3, 2021

'Consider booster dose for 40-plus age group'

The Indian SARS-CoV-2 Genomics Consortium (INSACOG ) has suggested a booster dose of anti-Covid vaccines can be considered for the 40-plus age group, prioritising those at high-risk or high-exposure as low levels of neutralising antibodies from existing vaccines may not be sufficient to neutralise the new variant- Omicron.

from Times of India https://ift.tt/3Ic25TX
https://ift.tt/eA8V8J

No comments:

Post a Comment

Subscribe Us

SoraBook

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum rhoncus vehicula tortor, vel cursus elit. Donec nec nisl felis. Pellentesque ultrices sem sit amet eros interdum, id elementum nisi ermentum.Vestibulum rhoncus vehicula tortor, vel cursus elit. Donec nec nisl felis. Pellentesque ultrices sem sit amet eros interdum, id elementum nisi fermentum.




Comments

Contact Form

Name

Email *

Message *